Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention
出版年份 2023 全文链接
标题
Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention
作者
关键词
-
出版物
EUROPEAN UROLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-01-05
DOI
10.1016/j.eururo.2022.12.021
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort
- (2022) Matthew B. Clements et al. EUROPEAN UROLOGY
- A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry
- (2022) Burcu F. Darst et al. EUROPEAN UROLOGY
- Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
- (2022) Minh-Phuong Huynh-Le et al. PROSTATE CANCER AND PROSTATIC DISEASES
- A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer
- (2022) Anna Plym et al. EUROPEAN UROLOGY
- PD13-03 LACK OF AWARENESS AND UNDERUTILIZATION OF GENETIC TESTING IN PROSTATE CANCER
- (2022) Sameer Thakker et al. JOURNAL OF UROLOGY
- Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing
- (2022) Stacy Loeb et al. Contemporary Clinical Trials
- Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program
- (2022) Meghana S Pagadala et al. JNCI-Journal of the National Cancer Institute
- Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
- (2021) David V. Conti et al. NATURE GENETICS
- Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
- (2021) Minh-Phuong Huynh-Le et al. Nature Communications
- Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk
- (2021) Burcu F. Darst et al. EUROPEAN UROLOGY
- Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer
- (2021) Anna Plym et al. JNCI-Journal of the National Cancer Institute
- Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients
- (2021) Jianfeng Xu et al. PROSTATE
- Common genetic and clinical risk factors: association with fatal prostate cancer in the Cohort of Swedish Men
- (2021) Minh-Phuong Huynh-Le et al. PROSTATE CANCER AND PROSTATIC DISEASES
- MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
- (2021) Martin Eklund et al. NEW ENGLAND JOURNAL OF MEDICINE
- Barriers and facilitators of germline genetic evaluation for prostate cancer
- (2021) Stacy Loeb et al. PROSTATE
- Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24
- (2021) Roshan A. Karunamuni et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice
- (2021) Veda N. Giri et al. Clinical Genitourinary Cancer
- Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer
- (2021) Daniel J. Lee et al. EUROPEAN UROLOGY
- A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
- (2021) Elizabeth K Bancroft et al. LANCET ONCOLOGY
- Age dependence of modern clinical risk groups for localized prostate cancer—A population‐based study
- (2020) Minh‐Phuong Huynh‐Le et al. CANCER
- A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry
- (2020) Burcu F. Darst et al. EUROPEAN UROLOGY
- BARCODE 1: A pilot study investigating the use of genetic profiling to identify men in the general population with the highest risk of prostate cancer to invite for targeted screening.
- (2020) Ros A. Eeles et al. JOURNAL OF CLINICAL ONCOLOGY
- A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data
- (2020) Minh-Phuong Huynh-Le et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
- (2020) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration
- (2020) Rana R. McKay et al. CANCER
- African‐specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
- (2020) Roshan A. Karunamuni et al. INTERNATIONAL JOURNAL OF CANCER
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate
- (2020) Robert T. Dess et al. JAMA Oncology
- Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis
- (2020) Zhuqing Shi et al. EUROPEAN UROLOGY
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
- (2019) Piper Nicolosi et al. JAMA Oncology
- Clinical use of current polygenic risk scores may exacerbate health disparities
- (2019) Alicia R. Martin et al. NATURE GENETICS
- Bringing prostate cancer germline genetics into clinical practice
- (2019) Sanjay Das et al. JOURNAL OF UROLOGY
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
- (2019) Jonas Hugosson et al. EUROPEAN UROLOGY
- Cancer statistics for African Americans, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality
- (2019) Robert T. Dess et al. JAMA Oncology
- Analysis of polygenic risk score usage and performance in diverse human populations
- (2019) L. Duncan et al. Nature Communications
- Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
- (2019) Tommy Nyberg et al. EUROPEAN UROLOGY
- Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
- (2019) Elizabeth C. Page et al. EUROPEAN UROLOGY
- Genome-wide germline correlates of the epigenetic landscape of prostate cancer
- (2019) Kathleen E. Houlahan et al. NATURE MEDICINE
- Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT
- (2019) Mahbubl Ahmed et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Ethnic disparities among men with prostate cancer undergoing germline testing
- (2019) Daniel Hyuck-Min Kwon et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Genetic factors, adherence to healthy lifestyle behavior, and risk of invasive breast cancer among women in the UK Biobank
- (2019) Rhonda S Arthur et al. JNCI-Journal of the National Cancer Institute
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
- (2018) Fredrick R. Schumacher et al. NATURE GENETICS
- The personal and clinical utility of polygenic risk scores
- (2018) Ali Torkamani et al. NATURE REVIEWS GENETICS
- Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
- (2017) Rong Na et al. EUROPEAN UROLOGY
- Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
- (2017) Julie Lecarpentier et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
- (2016) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
- (2016) Freddie C. Hamdy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial
- (2016) Haitao Chen et al. PROSTATE
- Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
- (2015) Elena Castro et al. EUROPEAN UROLOGY
- Spatial genomic heterogeneity within localized, multifocal prostate cancer
- (2015) Paul C Boutros et al. NATURE GENETICS
- Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
- (2015) Colin S Cooper et al. NATURE GENETICS
- Overdiagnosis and Overtreatment of Prostate Cancer
- (2014) Stacy Loeb et al. EUROPEAN UROLOGY
- Trends in Disparate Treatment of African American Men With Localized Prostate Cancer Across National Comprehensive Cancer Network Risk Groups
- (2014) Brandon A. Mahal et al. UROLOGY
- Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
- (2013) Ian M. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
- (2012) Robert Karlsson et al. EUROPEAN UROLOGY
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
- (2011) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Multifocal prostate cancer: biologic, prognostic, and therapeutic implications
- (2010) Matei Andreoiu et al. HUMAN PATHOLOGY
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started